These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8149691)

  • 1. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization of urinary calcium oxalate at standardized osmolality and pH in the frozen state.
    Gohel MD; Shum DK; Li MK
    Clin Chim Acta; 1994 Nov; 231(1):11-22. PubMed ID: 7704943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
    Kalaiselvi P; Udayapriya KL; Selvam R
    BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.
    Yamaguchi S; Yoshioka T; Utsunomiya M; Koide T; Osafune M; Okuyama A; Sonoda T
    Urol Res; 1993 May; 21(3):187-92. PubMed ID: 8342253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fasting and time of day on the urinary excretion of chondroitin 4/6 sulphate, dermatan sulphate and four chondroitinase ABC resistant glycosaminoglycans.
    Poulsen JH; Gregersen H
    Scand J Clin Lab Invest; 1983 Dec; 43(8):665-70. PubMed ID: 6420878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pH on the urinary inhibition of calcium oxalate crystal growth.
    Tiselius HG
    Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine.
    Rodgers AL; Ball D; Harper W
    Scanning Microsc; 1994 Mar; 8(1):71-7. PubMed ID: 7973501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionation with ethanol of human urinary glycosaminoglycans.
    Endo M; Namiki O; Yosizawa Z
    Tohoku J Exp Med; 1980 May; 131(1):23-8. PubMed ID: 6773184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary calcium oxalate saturation in 'stone formers' and normal subjects: an application of the EQUIL2 program.
    Robert M; Boularan AM; Colette C; Averous M; Monnier L
    Br J Urol; 1994 Apr; 73(4):358-61. PubMed ID: 8199821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine.
    Gohel MD; Shum DK; Li MK
    Urol Res; 1992; 20(1):13-7. PubMed ID: 1736481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans.
    Erkurt B; Ilker Y; Budak Y; Ozveren B; Türkeri L; Akdas A
    J Endourol; 1999 Oct; 13(8):553-7. PubMed ID: 10597124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation of urinary heparan sulfate and chondroitin sulfate and their inhibitory activity of calcium oxalate crystal growth].
    Iwata H; Terado T; Kin M; Nishio S; Matsumoto A; Takeuchi M
    Nihon Hinyokika Gakkai Zasshi; 1991 Mar; 82(3):405-11. PubMed ID: 1906557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.